Global Molecular Quality Controls Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Molecular Quality Controls Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Quality control products monitor the entire molecular diagnostic test process, including the extraction, amplification and detection steps. Molecular Quality Controls can be divided into Single Analyte Controls and Multi Analyte Controls, which are widely used in oncology, infectious diseases, blood screening, genetic testing and other fields.

Market Overview:

The latest research study on the global Molecular Quality Controls market finds that the global Molecular Quality Controls market reached a value of USD 188.19 million in 2022. It’s expected that the market will achieve USD 290.56 million by 2028, exhibiting a CAGR of 7.51% during the forecast period.

Opportunities and Drivers

Clinical laboratory has been proved to be one of the most basic units in the current value chain of healthcare industry. Clinical laboratory tests not only help to identify diseases, but also help to further monitor the efficacy of treatment. Nowadays, clinical laboratories all over the world are seeking national and international accreditation, mainly to ensure more reliable and better laboratory services. The Clinical Laboratory Improvement Amendments (CLIA) is the most important factor to comprehensively reform the overall regulatory structure of American laboratory industry.

Diagnosis helps health care providers to screen or monitor specific diseases or conditions. It also helps to assess the health status of patients, so as to make clinical decisions for patient care. The Clinical Laboratory Improvement Amendments (CLIA) regulates laboratory testing, and requires clinical laboratories to be certified by the Center for Medicare and Medicaid Services (CMS) before accepting human samples for diagnostic testing. According to the types of diagnostic tests conducted by the laboratory, the laboratory can obtain various types of CLIA certificates. Three federal agencies are responsible for CLIA: The Food and Drug Administration (FDA), Center for Medicaid Services (CMS), and the Centers for Disease Control and Prevention (CDC). Each agency has a unique role in assuring quality laboratory testing.

Increasing number of accredited clinical laboratories will promote the demand for molecular quality controls.

Region Overview:

From 2023-2028, North America is estimated to witness robust growth prospects.

Company Overview:

The top three companies are LGC (Seracare Life Sciences), Thermo Fisher Scientific, Bio-Rad Laboratories Inc, with the revenue market share of 29.57%, 16.84%, 10.08% in 2021.

SeraCare, part of LGC's Clinical Diagnostics Division, enables the promise of precision medicine by advancing the understanding of disease and providing assurance of the diagnostic result. Founded in 1984, SeraCare has been a trusted partner and worldwide supplier to the diagnostic testing industry for over 30 years, advancing the development of clinical genomics, molecular, and serological diagnostics with innovative technology, quality controls, reagents, and biological materials.

Thermo Fisher Scientific is an American supplier of scientific instrumentation, reagents and consumables, and software services. Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. Thermo Fisher has acquired other reagent, consumable, instrumentation, and service providers, including: Life Technologies Corporation (2013), Alfa Aesar (2015), Affymetrix (2016), FEI Company (2016), and BD Advanced Bioprocessing (2018).

Segmentation Overview:

Among different product types, Single Analyte Controls segment is anticipated to contribute the largest market share in 2028.

Application Overview:

By application, the Infectious Disease segment occupied the biggest share from 2018 to 2022.

Key Companies in the global Molecular Quality Controls market covered in Chapter 3:

Vircell
Qnostics
Asuragen
Microbiologics
Bio-Rad Laboratories Inc
Thermo Fisher Scientific
Zeptometrix Corporation
LGC (Seracare Life Sciences)
Microbix
Maine Molecular Controls, Inc.

In Chapter 4 and Chapter 14.2, on the basis of types, the Molecular Quality Controls market from 2018 to 2029 is primarily split into:

Single Analyte Controls
Multi Analyte Controls

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Molecular Quality Controls market from 2018 to 2029 covers:

Oncology
Infectious Disease
Blood Screening
Genetic Testing
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)